Goulet Olivier, Abi Nader Elie, Pigneur Bénédicte, Lambe Cécile
Department of Pediatric Gastroenterology-Hepatology-Nutrition, National Reference Center for Rare Digestive Diseases, Pediatric Intestinal Failure Rehabilitation Center, Hôpital Necker-Enfants Malades, University Sorbonne-Paris-Cité Paris Descartes Medical School, Paris, France.
Pediatr Gastroenterol Hepatol Nutr. 2019 Jul;22(4):303-329. doi: 10.5223/pghn.2019.22.4.303. Epub 2019 Jun 27.
Intestinal failure (IF) is the critical reduction of the gut mass or its function below the minimum needed to absorb nutrients and fluids required for adequate growth in children. Severe IF requires parenteral nutrition (PN). Pediatric IF is most commonly due to congenital or neonatal intestinal diseases or malformations divided into 3 groups: 1) reduced intestinal length and consequently reduced absorptive surface, such as in short bowel syndrome (SBS) or extensive aganglionosis; 2) abnormal development of the intestinal mucosa such as congenital diseases of enterocyte development; 3) extensive motility dysfunction such as chronic intestinal pseudo-obstruction syndromes. The leading cause of IF in childhood is the SBS. In clinical practice the degree of IF may be indirectly measured by the level of PN required for normal or catch up growth. Other indicators such as serum citrulline have not proven to be highly reliable prognostic factors in children. The last decades have allowed the development of highly sophisticated nutrient solutions consisting of optimal combinations of macronutrients and micronutrients as well as guidelines, promoting PN as a safe and efficient feeding technique. However, IF that requires long-term PN may be associated with various complications including infections, growth failure, metabolic disorders, and bone disease. IF Associated Liver Disease may be a limiting factor. However, changes in the global management of IF pediatric patients, especially since the setup of intestinal rehabilitation centres did change the prognosis thus limiting "nutritional failure" which is considered as a major indication for intestinal transplantation (ITx) or combined liver-ITx.
肠衰竭(IF)是指肠道质量或其功能严重降低,低于儿童充分生长所需的吸收营养物质和液体的最低水平。严重的肠衰竭需要肠外营养(PN)。小儿肠衰竭最常见的原因是先天性或新生儿肠道疾病或畸形,可分为3组:1)肠长度减少,从而吸收表面积减少,如短肠综合征(SBS)或广泛性神经节缺失;2)肠黏膜发育异常,如肠上皮细胞发育的先天性疾病;3)广泛性动力功能障碍,如慢性肠假性梗阻综合征。儿童期肠衰竭的主要原因是短肠综合征。在临床实践中,肠衰竭的程度可通过正常或追赶生长所需的肠外营养水平间接测量。其他指标如血清瓜氨酸尚未被证明是儿童高度可靠的预后因素。在过去几十年中,已经开发出了由宏量营养素和微量营养素的最佳组合以及指南组成的高度复杂的营养液,将肠外营养推广为一种安全有效的喂养技术。然而,需要长期肠外营养的肠衰竭可能与各种并发症相关,包括感染、生长发育不良、代谢紊乱和骨病。肠衰竭相关肝病可能是一个限制因素。然而,小儿肠衰竭患者全球管理的变化,特别是自肠道康复中心设立以来,确实改变了预后,从而限制了“营养衰竭”,而营养衰竭被认为是肠移植(ITx)或联合肝-肠移植的主要指征。